PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Alliance
-
-
Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
-
Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
-
Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
-
Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
-
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
-
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
-
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Categories
Alliance Committee
Browse by Year